atopic dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Signed informed consent (or by guardian for those minors); Clinical diagnosis of AD (Hanifin and Rajka criteria); Moderate to Severe flared patients (Rajka and Langeland criteria); Between the age of 5 to 25 years; The course of disease more than 1 year, and the time of anesis less than 3 months.
Exclusion criteria
Exclusion criteria: Unmoral full blood counts and renal and hepatic founction tests; Had any other serious concomitant illness; Other severe skin disease; Who had received systematic corticosteroids, antibiotics, PUVA, or other immunosuppressive treatment within the previous 2 weeks; Pregnancy or intending to become Pregnancy, or were breastfeeding; Epilepsy; Patient included in all other studies; known hypersensitivity to the drug; Abuse of drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SCORAD (SCORing Atopic Dermatitis; | — |
Secondary
| Measure | Time frame |
|---|---|
| DLQI (The Dermatology Life Quality Index) or CDLQI;Patients' self-assessment on the severity of disease; | — |
Countries
China